Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7249547rdf:typepubmed:Citationlld:pubmed
pubmed-article:7249547lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:7249547lifeskim:mentionsumls-concept:C0016536lld:lifeskim
pubmed-article:7249547lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:7249547lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:7249547lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7249547lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:7249547pubmed:issue6lld:pubmed
pubmed-article:7249547pubmed:dateCreated1981-9-22lld:pubmed
pubmed-article:7249547pubmed:abstractText1. The immediate haemodynamic and metabolic effects of intravenous administration of DL-propranolol and D-propranolol were studied in healthy male subjects at rest and during dynamic forearm exercise. The dose of DL-propranolol and of D-propranolol was 0.1 and 1.0 mg/kg body weight respectively. 2. DL-Propranolol reduced heart rate significantly at rest, during forearm exercise and post-exercise, whereas D-propranolol had a lesser effect on heart rate which was significant only at the end of the exercise period. Arterial blood pressure and forearm blood flow were unchanged after either drug. 3. Both drugs reduced the release of lactate from the exercising forearm. Forearm exchange of oxygen, glucose, free fatty acids and triglycerides remained unchanged. 4. The arterial blood glucose concentration increased after D-propranolol, but was unchanged after DL-propranolol. The arterial serum free fatty acid concentration decreased after DL-propranolol, but was not changed after D-propranolol. Arterial concentrations of lactate and triglycerides were not influenced by the drugs. 5. The chronotropic response to beta-adrenoceptor blockade appears to be stereoselective, suggesting specific blockade of beta-adrenoceptors. Metabolic responses to beta-adrenoceptor blockade are difficult to explain in terms of the known adrenoceptor system and may be due to non-specific actions of beta-adrenoceptor antagonists. An exception is inhibition of lipolysis, which is probably mediated via beta-adrenoceptors.lld:pubmed
pubmed-article:7249547pubmed:languageenglld:pubmed
pubmed-article:7249547pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7249547pubmed:citationSubsetIMlld:pubmed
pubmed-article:7249547pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7249547pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7249547pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7249547pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7249547pubmed:statusMEDLINElld:pubmed
pubmed-article:7249547pubmed:monthJunlld:pubmed
pubmed-article:7249547pubmed:issn0143-5221lld:pubmed
pubmed-article:7249547pubmed:authorpubmed-author:Trap-JensenJJlld:pubmed
pubmed-article:7249547pubmed:authorpubmed-author:SvendsenT LTLlld:pubmed
pubmed-article:7249547pubmed:authorpubmed-author:HartlingO JOJlld:pubmed
pubmed-article:7249547pubmed:issnTypePrintlld:pubmed
pubmed-article:7249547pubmed:volume60lld:pubmed
pubmed-article:7249547pubmed:ownerNLMlld:pubmed
pubmed-article:7249547pubmed:authorsCompleteYlld:pubmed
pubmed-article:7249547pubmed:pagination675-9lld:pubmed
pubmed-article:7249547pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:meshHeadingpubmed-meshheading:7249547-...lld:pubmed
pubmed-article:7249547pubmed:year1981lld:pubmed
pubmed-article:7249547pubmed:articleTitleSystemic and forearm haemodynamic and metabolic effects of racemic propranolol or D-propranolol in healthy subjects.lld:pubmed
pubmed-article:7249547pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7249547pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7249547pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7249547lld:pubmed